Collectively, 4-AAQB inhibits hepatoma cells proliferation and metastasis via suppressing PI3K/Akt/mTOR, ERK pathways and inhibition of Rho GTPase signaling pathway via suppressing VEGF production [9]. Here, MTOR is linked to hepatocellular carcinoma.